nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—muscle cancer	0.719	1	CbGaD
Oxaprozin—PTGS2—Etoposide—muscle cancer	0.093	0.542	CbGbCtD
Oxaprozin—PTGS1—Etoposide—muscle cancer	0.0785	0.458	CbGbCtD
Oxaprozin—Fenbufen—PTGS2—muscle cancer	0.000609	0.489	CrCbGaD
Oxaprozin—Bladder pain—Methotrexate—muscle cancer	0.000436	0.00404	CcSEcCtD
Oxaprozin—Ecchymosis—Methotrexate—muscle cancer	0.000436	0.00404	CcSEcCtD
Oxaprozin—Urine output increased—Methotrexate—muscle cancer	0.000436	0.00404	CcSEcCtD
Oxaprozin—Leukopenia—Dactinomycin—muscle cancer	0.000435	0.00403	CcSEcCtD
Oxaprozin—Agranulocytosis—Etoposide—muscle cancer	0.00042	0.00389	CcSEcCtD
Oxaprozin—Sepsis—Methotrexate—muscle cancer	0.000419	0.00388	CcSEcCtD
Oxaprozin—Lymphadenopathy—Methotrexate—muscle cancer	0.00041	0.0038	CcSEcCtD
Oxaprozin—Eructation—Doxorubicin—muscle cancer	0.00041	0.0038	CcSEcCtD
Oxaprozin—Discomfort—Dactinomycin—muscle cancer	0.000409	0.00379	CcSEcCtD
Oxaprozin—Cystitis noninfective—Doxorubicin—muscle cancer	0.000408	0.00378	CcSEcCtD
Oxaprozin—Melaena—Doxorubicin—muscle cancer	0.000408	0.00378	CcSEcCtD
Oxaprozin—Cystitis—Doxorubicin—muscle cancer	0.000403	0.00373	CcSEcCtD
Oxaprozin—Anaemia—Vincristine—muscle cancer	0.000402	0.00372	CcSEcCtD
Oxaprozin—Photosensitivity—Methotrexate—muscle cancer	0.000399	0.00369	CcSEcCtD
Oxaprozin—Polyuria—Methotrexate—muscle cancer	0.000399	0.00369	CcSEcCtD
Oxaprozin—Oedema—Dactinomycin—muscle cancer	0.000397	0.00368	CcSEcCtD
Oxaprozin—Infection—Dactinomycin—muscle cancer	0.000394	0.00365	CcSEcCtD
Oxaprozin—Aplastic anaemia—Doxorubicin—muscle cancer	0.000392	0.00363	CcSEcCtD
Oxaprozin—Vertigo—Vincristine—muscle cancer	0.00039	0.00361	CcSEcCtD
Oxaprozin—Hepatic failure—Methotrexate—muscle cancer	0.00039	0.00361	CcSEcCtD
Oxaprozin—Leukopenia—Vincristine—muscle cancer	0.000389	0.0036	CcSEcCtD
Oxaprozin—Thrombocytopenia—Dactinomycin—muscle cancer	0.000389	0.0036	CcSEcCtD
Oxaprozin—Erythema multiforme—Etoposide—muscle cancer	0.000382	0.00354	CcSEcCtD
Oxaprozin—Coma—Doxorubicin—muscle cancer	0.000382	0.00353	CcSEcCtD
Oxaprozin—Oesophagitis—Doxorubicin—muscle cancer	0.000382	0.00353	CcSEcCtD
Oxaprozin—Renal failure acute—Methotrexate—muscle cancer	0.000379	0.00351	CcSEcCtD
Oxaprozin—Anorexia—Dactinomycin—muscle cancer	0.000378	0.0035	CcSEcCtD
Oxaprozin—Ecchymosis—Doxorubicin—muscle cancer	0.000378	0.0035	CcSEcCtD
Oxaprozin—Bladder pain—Doxorubicin—muscle cancer	0.000378	0.0035	CcSEcCtD
Oxaprozin—Convulsion—Vincristine—muscle cancer	0.000377	0.00349	CcSEcCtD
Oxaprozin—Hypertension—Vincristine—muscle cancer	0.000375	0.00347	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000371	0.00344	CcSEcCtD
Oxaprozin—Sepsis—Doxorubicin—muscle cancer	0.000362	0.00336	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000362	0.00335	CcSEcCtD
Oxaprozin—Alopecia—Etoposide—muscle cancer	0.000357	0.00331	CcSEcCtD
Oxaprozin—Lethargy—Methotrexate—muscle cancer	0.000357	0.00331	CcSEcCtD
Oxaprozin—Lymphadenopathy—Doxorubicin—muscle cancer	0.000355	0.00329	CcSEcCtD
Oxaprozin—Oedema—Vincristine—muscle cancer	0.000355	0.00328	CcSEcCtD
Oxaprozin—Anaphylactic shock—Vincristine—muscle cancer	0.000355	0.00328	CcSEcCtD
Oxaprozin—Infection—Vincristine—muscle cancer	0.000352	0.00326	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS2—muscle cancer	0.00035	0.281	CrCbGaD
Oxaprozin—Thrombocytopenia—Vincristine—muscle cancer	0.000347	0.00322	CcSEcCtD
Oxaprozin—Photosensitivity—Doxorubicin—muscle cancer	0.000345	0.0032	CcSEcCtD
Oxaprozin—Decreased appetite—Dactinomycin—muscle cancer	0.000345	0.00319	CcSEcCtD
Oxaprozin—Dysgeusia—Etoposide—muscle cancer	0.000345	0.00319	CcSEcCtD
Oxaprozin—Hyperhidrosis—Vincristine—muscle cancer	0.000343	0.00317	CcSEcCtD
Oxaprozin—Vascular purpura—Doxorubicin—muscle cancer	0.000339	0.00314	CcSEcCtD
Oxaprozin—Anorexia—Vincristine—muscle cancer	0.000338	0.00313	CcSEcCtD
Oxaprozin—Hepatic failure—Doxorubicin—muscle cancer	0.000337	0.00312	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000334	0.0031	CcSEcCtD
Oxaprozin—Hypotension—Vincristine—muscle cancer	0.000331	0.00307	CcSEcCtD
Oxaprozin—Renal failure acute—Doxorubicin—muscle cancer	0.000328	0.00304	CcSEcCtD
Oxaprozin—Feeling abnormal—Dactinomycin—muscle cancer	0.000327	0.00303	CcSEcCtD
Oxaprozin—Ill-defined disorder—Etoposide—muscle cancer	0.000327	0.00302	CcSEcCtD
Oxaprozin—Anaemia—Etoposide—muscle cancer	0.000325	0.00301	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000325	0.00301	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000321	0.00297	CcSEcCtD
Oxaprozin—Insomnia—Vincristine—muscle cancer	0.000321	0.00297	CcSEcCtD
Oxaprozin—Renal impairment—Doxorubicin—muscle cancer	0.000319	0.00295	CcSEcCtD
Oxaprozin—Paraesthesia—Vincristine—muscle cancer	0.000318	0.00295	CcSEcCtD
Oxaprozin—Malaise—Etoposide—muscle cancer	0.000317	0.00294	CcSEcCtD
Oxaprozin—Vertigo—Etoposide—muscle cancer	0.000316	0.00293	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000315	0.00292	CcSEcCtD
Oxaprozin—Leukopenia—Etoposide—muscle cancer	0.000315	0.00292	CcSEcCtD
Oxaprozin—Purpura—Doxorubicin—muscle cancer	0.000315	0.00291	CcSEcCtD
Oxaprozin—Abdominal pain—Dactinomycin—muscle cancer	0.000314	0.00291	CcSEcCtD
Oxaprozin—Body temperature increased—Dactinomycin—muscle cancer	0.000314	0.00291	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000313	0.0029	CcSEcCtD
Oxaprozin—Loss of consciousness—Etoposide—muscle cancer	0.000309	0.00286	CcSEcCtD
Oxaprozin—Lethargy—Doxorubicin—muscle cancer	0.000309	0.00286	CcSEcCtD
Oxaprozin—Decreased appetite—Vincristine—muscle cancer	0.000308	0.00285	CcSEcCtD
Oxaprozin—Convulsion—Etoposide—muscle cancer	0.000305	0.00282	CcSEcCtD
Oxaprozin—Hypertension—Etoposide—muscle cancer	0.000304	0.00281	CcSEcCtD
Oxaprozin—Constipation—Vincristine—muscle cancer	0.000303	0.00281	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000303	0.00281	CcSEcCtD
Oxaprozin—Asthma—Methotrexate—muscle cancer	0.000303	0.0028	CcSEcCtD
Oxaprozin—Eosinophilia—Methotrexate—muscle cancer	0.0003	0.00277	CcSEcCtD
Oxaprozin—Pancreatitis—Methotrexate—muscle cancer	0.000297	0.00275	CcSEcCtD
Oxaprozin—Discomfort—Etoposide—muscle cancer	0.000296	0.00274	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Vincristine—muscle cancer	0.00029	0.00269	CcSEcCtD
Oxaprozin—Confusional state—Etoposide—muscle cancer	0.00029	0.00268	CcSEcCtD
Oxaprozin—Pancytopenia—Methotrexate—muscle cancer	0.000287	0.00266	CcSEcCtD
Oxaprozin—Anaphylactic shock—Etoposide—muscle cancer	0.000287	0.00266	CcSEcCtD
Oxaprozin—Flurbiprofen—PTGS2—muscle cancer	0.000285	0.229	CrCbGaD
Oxaprozin—Infection—Etoposide—muscle cancer	0.000285	0.00264	CcSEcCtD
Oxaprozin—Asthenia—Dactinomycin—muscle cancer	0.000285	0.00264	CcSEcCtD
Oxaprozin—Dysuria—Methotrexate—muscle cancer	0.000283	0.00262	CcSEcCtD
Oxaprozin—Thrombocytopenia—Etoposide—muscle cancer	0.000281	0.0026	CcSEcCtD
Oxaprozin—Tachycardia—Etoposide—muscle cancer	0.00028	0.0026	CcSEcCtD
Oxaprozin—Abdominal pain—Vincristine—muscle cancer	0.00028	0.0026	CcSEcCtD
Oxaprozin—Body temperature increased—Vincristine—muscle cancer	0.00028	0.0026	CcSEcCtD
Oxaprozin—Hyperhidrosis—Etoposide—muscle cancer	0.000278	0.00257	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—muscle cancer	0.000277	0.00256	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Methotrexate—muscle cancer	0.000276	0.00256	CcSEcCtD
Oxaprozin—Anorexia—Etoposide—muscle cancer	0.000274	0.00254	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000273	0.00253	CcSEcCtD
Oxaprozin—Diarrhoea—Dactinomycin—muscle cancer	0.000272	0.00251	CcSEcCtD
Oxaprozin—Pneumonia—Methotrexate—muscle cancer	0.000271	0.00251	CcSEcCtD
Oxaprozin—Drowsiness—Methotrexate—muscle cancer	0.00027	0.0025	CcSEcCtD
Oxaprozin—Hypotension—Etoposide—muscle cancer	0.000268	0.00249	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—muscle cancer	0.000268	0.00248	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000268	0.00248	CcSEcCtD
Oxaprozin—Renal failure—Methotrexate—muscle cancer	0.000265	0.00246	CcSEcCtD
Oxaprozin—Stomatitis—Methotrexate—muscle cancer	0.000263	0.00244	CcSEcCtD
Oxaprozin—Conjunctivitis—Methotrexate—muscle cancer	0.000262	0.00243	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—muscle cancer	0.000262	0.00243	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—muscle cancer	0.000259	0.0024	CcSEcCtD
Oxaprozin—Paraesthesia—Etoposide—muscle cancer	0.000258	0.00239	CcSEcCtD
Oxaprozin—Haematuria—Methotrexate—muscle cancer	0.000257	0.00238	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—muscle cancer	0.000257	0.00238	CcSEcCtD
Oxaprozin—Dyspnoea—Etoposide—muscle cancer	0.000256	0.00237	CcSEcCtD
Oxaprozin—Somnolence—Etoposide—muscle cancer	0.000255	0.00236	CcSEcCtD
Oxaprozin—Asthenia—Vincristine—muscle cancer	0.000254	0.00236	CcSEcCtD
Oxaprozin—Vomiting—Dactinomycin—muscle cancer	0.000252	0.00234	CcSEcCtD
Oxaprozin—Agranulocytosis—Methotrexate—muscle cancer	0.000252	0.00233	CcSEcCtD
Oxaprozin—Rash—Dactinomycin—muscle cancer	0.00025	0.00232	CcSEcCtD
Oxaprozin—Decreased appetite—Etoposide—muscle cancer	0.00025	0.00231	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—muscle cancer	0.000249	0.0023	CcSEcCtD
Oxaprozin—Constipation—Etoposide—muscle cancer	0.000246	0.00227	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—muscle cancer	0.000245	0.00227	CcSEcCtD
Oxaprozin—Haemoglobin—Methotrexate—muscle cancer	0.000243	0.00225	CcSEcCtD
Oxaprozin—Diarrhoea—Vincristine—muscle cancer	0.000243	0.00225	CcSEcCtD
Oxaprozin—Haemorrhage—Methotrexate—muscle cancer	0.000242	0.00224	CcSEcCtD
Oxaprozin—Hepatitis—Methotrexate—muscle cancer	0.000242	0.00224	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000239	0.00221	CcSEcCtD
Oxaprozin—Feeling abnormal—Etoposide—muscle cancer	0.000237	0.00219	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—muscle cancer	0.000236	0.00219	CcSEcCtD
Oxaprozin—Nausea—Dactinomycin—muscle cancer	0.000236	0.00218	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—muscle cancer	0.000235	0.00218	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Etoposide—muscle cancer	0.000235	0.00218	CcSEcCtD
Oxaprozin—Dizziness—Vincristine—muscle cancer	0.000235	0.00217	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—muscle cancer	0.000234	0.00216	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000232	0.00214	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—muscle cancer	0.00023	0.00213	CcSEcCtD
Oxaprozin—Erythema multiforme—Methotrexate—muscle cancer	0.000229	0.00212	CcSEcCtD
Oxaprozin—Urticaria—Etoposide—muscle cancer	0.000228	0.00211	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—muscle cancer	0.000228	0.00211	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—muscle cancer	0.000228	0.00211	CcSEcCtD
Oxaprozin—Abdominal pain—Etoposide—muscle cancer	0.000227	0.0021	CcSEcCtD
Oxaprozin—Body temperature increased—Etoposide—muscle cancer	0.000227	0.0021	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—muscle cancer	0.000227	0.0021	CcSEcCtD
Oxaprozin—Tinnitus—Methotrexate—muscle cancer	0.000226	0.00209	CcSEcCtD
Oxaprozin—Vomiting—Vincristine—muscle cancer	0.000226	0.00209	CcSEcCtD
Oxaprozin—Rash—Vincristine—muscle cancer	0.000224	0.00207	CcSEcCtD
Oxaprozin—Dermatitis—Vincristine—muscle cancer	0.000223	0.00207	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—muscle cancer	0.000223	0.00206	CcSEcCtD
Oxaprozin—Headache—Vincristine—muscle cancer	0.000222	0.00206	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—muscle cancer	0.000219	0.00203	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—muscle cancer	0.000218	0.00202	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—muscle cancer	0.000214	0.00198	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—muscle cancer	0.000211	0.00195	CcSEcCtD
Oxaprozin—Nausea—Vincristine—muscle cancer	0.000211	0.00195	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—muscle cancer	0.00021	0.00194	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—muscle cancer	0.00021	0.00194	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—muscle cancer	0.000207	0.00191	CcSEcCtD
Oxaprozin—Asthenia—Etoposide—muscle cancer	0.000206	0.00191	CcSEcCtD
Oxaprozin—Pruritus—Etoposide—muscle cancer	0.000203	0.00188	CcSEcCtD
Oxaprozin—Vision blurred—Methotrexate—muscle cancer	0.000199	0.00184	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—muscle cancer	0.000198	0.00184	CcSEcCtD
Oxaprozin—Diarrhoea—Etoposide—muscle cancer	0.000197	0.00182	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—muscle cancer	0.000196	0.00181	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—muscle cancer	0.000196	0.00181	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—muscle cancer	0.000195	0.0018	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—muscle cancer	0.00019	0.00176	CcSEcCtD
Oxaprozin—Dizziness—Etoposide—muscle cancer	0.00019	0.00176	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—muscle cancer	0.000189	0.00175	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—muscle cancer	0.000189	0.00175	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—muscle cancer	0.000187	0.00173	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—muscle cancer	0.000185	0.00172	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—muscle cancer	0.000183	0.00169	CcSEcCtD
Oxaprozin—Vomiting—Etoposide—muscle cancer	0.000183	0.00169	CcSEcCtD
Oxaprozin—Rash—Etoposide—muscle cancer	0.000181	0.00168	CcSEcCtD
Oxaprozin—Dermatitis—Etoposide—muscle cancer	0.000181	0.00168	CcSEcCtD
Oxaprozin—Headache—Etoposide—muscle cancer	0.00018	0.00167	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—muscle cancer	0.00018	0.00167	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—muscle cancer	0.000179	0.00166	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—muscle cancer	0.000179	0.00166	CcSEcCtD
Oxaprozin—Discomfort—Methotrexate—muscle cancer	0.000177	0.00164	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—muscle cancer	0.000177	0.00164	CcSEcCtD
Oxaprozin—Confusional state—Methotrexate—muscle cancer	0.000174	0.00161	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—muscle cancer	0.000172	0.00159	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—muscle cancer	0.000172	0.00159	CcSEcCtD
Oxaprozin—Infection—Methotrexate—muscle cancer	0.000171	0.00158	CcSEcCtD
Oxaprozin—Nausea—Etoposide—muscle cancer	0.000171	0.00158	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000169	0.00157	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—muscle cancer	0.000169	0.00156	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—muscle cancer	0.000169	0.00156	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—muscle cancer	0.000166	0.00154	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—muscle cancer	0.000165	0.00152	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—muscle cancer	0.000164	0.00152	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—muscle cancer	0.000164	0.00152	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—muscle cancer	0.000164	0.00152	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—muscle cancer	0.000163	0.00151	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—muscle cancer	0.000161	0.00149	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—muscle cancer	0.000161	0.00149	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—muscle cancer	0.00016	0.00149	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—muscle cancer	0.000158	0.00146	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—muscle cancer	0.000158	0.00146	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—muscle cancer	0.000156	0.00144	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—muscle cancer	0.000155	0.00143	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—muscle cancer	0.000155	0.00143	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—muscle cancer	0.000154	0.00142	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—muscle cancer	0.000153	0.00142	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—muscle cancer	0.000153	0.00142	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—muscle cancer	0.000152	0.00141	CcSEcCtD
Oxaprozin—Dyspepsia—Methotrexate—muscle cancer	0.000151	0.0014	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—muscle cancer	0.00015	0.00139	CcSEcCtD
Oxaprozin—Decreased appetite—Methotrexate—muscle cancer	0.00015	0.00139	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000149	0.00138	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—muscle cancer	0.000149	0.00138	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—muscle cancer	0.000148	0.00137	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—muscle cancer	0.000147	0.00136	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000146	0.00135	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—muscle cancer	0.000145	0.00135	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000144	0.00133	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—muscle cancer	0.000142	0.00132	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—muscle cancer	0.000142	0.00131	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000141	0.0013	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—muscle cancer	0.000139	0.00129	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—muscle cancer	0.000137	0.00127	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—muscle cancer	0.000136	0.00126	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—muscle cancer	0.000136	0.00126	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—muscle cancer	0.000135	0.00125	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—muscle cancer	0.000134	0.00124	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—muscle cancer	0.000133	0.00123	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—muscle cancer	0.000132	0.00123	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—muscle cancer	0.000131	0.00121	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—muscle cancer	0.00013	0.0012	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—muscle cancer	0.000127	0.00118	CcSEcCtD
Oxaprozin—Asthenia—Methotrexate—muscle cancer	0.000123	0.00114	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—muscle cancer	0.000123	0.00114	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000122	0.00113	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—muscle cancer	0.000122	0.00113	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—muscle cancer	0.000118	0.0011	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—muscle cancer	0.000118	0.00109	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—muscle cancer	0.000118	0.00109	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—muscle cancer	0.000118	0.00109	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—muscle cancer	0.000114	0.00105	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—muscle cancer	0.000109	0.00101	CcSEcCtD
Oxaprozin—Rash—Methotrexate—muscle cancer	0.000109	0.001	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—muscle cancer	0.000108	0.001	CcSEcCtD
Oxaprozin—Headache—Methotrexate—muscle cancer	0.000108	0.000998	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—muscle cancer	0.000107	0.00099	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—muscle cancer	0.000105	0.000976	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—muscle cancer	0.000102	0.000946	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—muscle cancer	0.000102	0.000944	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—muscle cancer	9.85e-05	0.000912	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—muscle cancer	9.48e-05	0.000877	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—muscle cancer	9.4e-05	0.00087	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—muscle cancer	9.39e-05	0.000869	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—muscle cancer	9.34e-05	0.000864	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—muscle cancer	8.85e-05	0.00082	CcSEcCtD
